An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients

An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients

The number of genomic aberrations known to be relevant in making therapeutic decisions for non-small cell lung cancer patients has increased in the past decade. Multiple molecular tests are required to reliably establish the presence of these aberrations, which is challenging because available tissu...

Full description

Bibliographic Details
Main Authors: Jiacong Wei, Anna A. Rybczynska, Pei Meng, Martijn Terpstra, Ali Saber, Jantine Sietzema, Wim Timens, Ed Schuuring, T. Jeroen N. Hiltermann, Harry. J.M. Groen, Anthonie J. van der Wekken, Anke van den Berg, Klaas Kok
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
RNA sequencing
non-small cell lung cancer
mutation
gene fusion
exon skipping
Online Access:https://www.mdpi.com/2072-6694/12/10/2843

Internet

https://www.mdpi.com/2072-6694/12/10/2843

Similar Items